Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
Metformin is the most used drug for type 2 diabetes (T2DM). Its antitumor activity has been described by clinical studies showing reduced risk of cancer development in T2DM patients, as well as management of T2DM compared with those receiving other glucose-lowering drugs. Metformin has a plethora of...
Main Authors: | Mirian Galliote Morale, Rodrigo Esaki Tamura, Ileana Gabriela Sanchez Rubio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/12/3/357 |
Similar Items
-
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
by: Yu Hua, et al.
Published: (2023-06-01) -
Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort study
by: Daniel J. Lee, et al.
Published: (2019-07-01) -
Thyroid Storm in Head and Neck Emergency Patients
by: Mohamed A. Radhi, et al.
Published: (2020-11-01) -
Preventive and Therapeutic Effect of Metformin in Head and Neck Cancer: A Concise Review
by: Cyril Bouland, et al.
Published: (2023-09-01) -
Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis
by: Yu Jiao, et al.
Published: (2022-05-01)